
Regulatory flexibility can make continuous improvement possible.
Jutta Look is the senior manager, CMC regulatory affairs at Novartis Pharma AG

Regulatory flexibility can make continuous improvement possible.

Second in a three-part series that discusses the complexities of QbD implementation in biotech development.

First in a three-part series that discusses the complexities of QbD implementation in biotech product development.

January 1st 2010

December 1st 2009

November 1st 2009